GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Samyang Genex Corp (XKRX:003945.PFD) » Definitions » EBIT

Samyang Genex (XKRX:003945.PFD) EBIT : ₩40,701.87 Mil (TTM As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is Samyang Genex EBIT?

Samyang Genex's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2015 was ₩14,116.53 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2015 was ₩40,701.87 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Samyang Genex's annualized ROC % for the quarter that ended in Sep. 2015 was 11.18%. Samyang Genex's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2015 was 28.99%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


Samyang Genex EBIT Historical Data

The historical data trend for Samyang Genex's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samyang Genex EBIT Chart

Samyang Genex Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
EBIT
Get a 7-Day Free Trial 44,614.40 30,007.30 33,177.55 31,457.67 37,113.14

Samyang Genex Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,794.56 1,006.55 10,514.44 15,064.34 14,116.53

Competitive Comparison of Samyang Genex's EBIT

For the Packaged Foods subindustry, Samyang Genex's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samyang Genex's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Samyang Genex's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Samyang Genex's EV-to-EBIT falls into.


;
;

Samyang Genex EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩40,701.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samyang Genex  (XKRX:003945.PFD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Samyang Genex's annualized ROC % for the quarter that ended in Sep. 2015 is calculated as:

ROC % (Q: Sep. 2015 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2015 ) + Invested Capital (Q: Sep. 2015 ))/ count )
=58471.828 * ( 1 - 42.86% )/( (305302.096 + 292165.085)/ 2 )
=33410.8025192/298733.5905
=11.18 %

where

Invested Capital(Q: Jun. 2015 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=495608.71 - 9944.704 - ( 195117.435 - max(0, 110697.829 - 291059.739+195117.435))
=305302.096

Invested Capital(Q: Sep. 2015 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=504141.994 - 44718.073 - ( 185584.701 - max(0, 110061.178 - 277320.014+185584.701))
=292165.085

Note: The Operating Income data used here is four times the quarterly (Sep. 2015) data.

2. Joel Greenblatt's definition of Return on Capital:

Samyang Genex's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2015 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2015 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2015  Q: Sep. 2015
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=56466.136/( ( (142027.494 + max(46885.708, 0)) + (159624.783 + max(41078.776, 0)) )/ 2 )
=56466.136/( ( 188913.202 + 200703.559 )/ 2 )
=56466.136/194808.3805
=28.99 %

where Working Capital is:

Working Capital(Q: Jun. 2015 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(31261.47 + 55328.349 + 9352.485) - (9944.704 + 0 + 39111.892)
=46885.708

Working Capital(Q: Sep. 2015 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(33495.454 + 51268.609 + 6971.2500000001) - (44718.073 + 0 + 5938.464)
=41078.776

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2015) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Samyang Genex's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2015 )
=40701.865/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samyang Genex EBIT Related Terms

Thank you for viewing the detailed overview of Samyang Genex's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Samyang Genex Business Description

Traded in Other Exchanges
N/A
Address
Samyang Genex Corporation operates two business such as food material and pharmaceutical business. The company's products are starch, starch sugars and anti cancer drug.

Samyang Genex Headlines

No Headlines